(Q40472868)

20 September 2017

1 reference

title

Surrogate biochemical markers: precise measurement for strategic drug and biologics development. (English)

1 reference

20 September 2017

Lee JW

1

1 reference

20 September 2017

Hulse JD

series ordinal

2

1 reference

20 September 2017

Colburn WA

series ordinal

3

1 reference

20 September 2017

language of work or name

1 reference

1 May 1995

1 reference

The Journal of Clinical Pharmacology

20 September 2017

published in

1 reference

20 September 2017

volume

35

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

464-470

1 reference

Cost of innovation in the pharmaceutical industry

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04089.X

Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04089.X

Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04089.X

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04089.X

Heparin pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04089.X

Pharmacodynamics, clinical indications, and adverse effects of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04089.X

Simultaneous pharmacokinetic and pharmacodynamic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04089.X

10.1002/J.1552-4604.1995.TB04089.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference